Chimeric adenoviruses
OwnerMenzo Havenga, Ronald Vogels +1inventors
InventorsMenzo Havenga, Ronald Vogels, Abraham Bout
Life of this patent
Estimating the term…
Loading patent…
OwnerMenzo Havenga, Ronald Vogels +1inventors
InventorsMenzo Havenga, Ronald Vogels, Abraham Bout
Estimating the term…
Methods and vector systems for generating chimeric recombinant adenoviruses. These hybrid adenoviruses contain a genome that is derived from different adenovirus serotypes. In particular, novel hybrid adenoviruses are disclosed that have improved properties for gene therapy purposes. These properties include, but are not limited to, a decreased sensitivity towards neutralizing antibodies, a modified host range, a change in the titer to which adenovirus can be grown, the ability to escape trapping in the liver upon in vivo systemic delivery, and absence or decreased infection of antigen presenting cells of the immune system, such as macrophages or dendritic cells. These chimeric adenoviruses thus represent improved tools for gene therapy and vaccination, since they overcome the limitations observed with the currently used serotype subgroup C adenoviruses.
A nucleic acid library comprising nucleic acid derived from different adenovirus serotypes.
A method for selecting and producing a chimeric adenovirus having a desired host range determined by at least one part of a fiber of a first adenovirus serotype and immunological properties determined by at least one part of at least one of a hexon or penton of a second adenovirus serotype, said method comprising:
A method of generating a library of chimeric adenoviruses, said method comprising:
A method for selecting and producing a chimeric adenovirus having a desired host range determined by at least one part of a fiber of a first adenovirus serotype, immunological properties determined by at least one part of at least one of a hexon or penton of a second adenovirus serotype, said method comprising:
Dependencies are inferred from the claim text.